Company / Total Debt
Cogent Biosciences, Inc. Total Debt History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$222.9M
FY2025
5-year range
$222.9M / $222.9M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#45 of 86
Health Care
What the data says
At $223M, Cogent Biosciences, Inc.'s total debt ranks #42 of 86 in the Health Care sector.
Based on SEC 10-K filings.
$223M in FY2025.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#42 of 86 in Health CareTop 48% of 86This company $222.9M Sector average $6.0B
▼
-96.3% below sector average
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $222.9M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026